← FDA DRUG APPROVALS

FDA ANDA · ANDA073396

CLOFIBRATE

Sponsor: BANNER PHARMACAPS

APPLICATION
ANDA073396
TYPE
ANDA
ORIGINAL APPROVAL
1992-03-20
LATEST ACTION
1996-12-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CLOFIBRATEDiscontinued
CLOFIBRATE 500MG · CAPSULE · ORAL

Approval history

1996-12-31Labeling · Supplement 1AP
1992-03-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →